Table 5.
Predictive performance of DB under different conditions of glucose metabolism regulation.
| Model 1* | Model 2 † | Model 3 ‡ | ||||
|---|---|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Normal glucose regulation | - | 0.317 | - | 0.180 | - | 0.319 |
| Q2 vs. Q1 | 0.768 (0.537–1.099) | 0.144 | 1.447 (0.982–2.132) | 0.062 | 1.440 (0.942–2.201) | 0.092 |
| Q3 vs. Q1 | 1.018 (0.730–1.419) | 0.069 | 1.406 (0.988–1.999) | 0.058 | 1.403 (0.932–2.111) | 0.105 |
| Q4 vs. Q1 | 1.056 (0.791–1.411) | 0.149 | 1.437 (1.001–2.065) | 0.050 | 1.339 (0.897–1.998) | 0.153 |
| Prediabetes | - | 0.714 | - | 0.535 | - | 0.767 |
| Q2 vs. Q1 | 0.862 (0.541–1.374) | 0.533 | 0.892 (0.556–1.431) | 0.636 | 0.836 (0.510–1.370) | 0.478 |
| Q3 vs. Q1 | 1.074 (0.691–1.671) | 0.750 | 1.184 (0.760–1.846) | 0.455 | 1.046 (0.648–1.690) | 0.853 |
| Q4 vs. Q1 | 1.083 (0.702–1.671) | 0.718 | 1.170 (0.758–1.806) | 0.479 | 1.054 (0.654–1.700) | 0.829 |
| Diabetes | - | 0.005 | - | 0.012 | - | 0.021 |
| Q2 vs. Q1 | 0.916 (0.675–1.242) | 0.572 | 0.999 (0.731–1.366) | 0.996 | 0.938 (0.673–1.309) | 0.707 |
| Q3 vs. Q1 | 1.323 (1.008–1.736) | 0.043 | 1.338 (1.010–1.773) | 0.042 | 1.270 (0.925–1.742) | 0.139 |
| Q4 vs. Q1 | 1.409 (1.081–1.837) | 0.011 | 1.446 (1.103–1.896) | 0.008 | 1.445 (1.076–1.940) | 0.014 |
*
Model 1 covariates: age, sex, and body mass index.
†
Model 2 covariate: SS II.
‡
Model 3 covariates: SS II, treatment strategies (PCI, CABG, or MT), previous history of stroke, body mass index, blood pressure, LDL-C, hs-CRP, and liver enzymes.